Physician profile
Alan Yee
NPI 1861418543
$4,015.13
in general payments reported to CMS, 2019-2025
36 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $558 · 2021: $595 · 2022: $792 · 2023: $619 · 2024: $390 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.24 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $828.32 | 2019-2023 | Stiolto Respimat, Ofev, Spiriva Respimat |
| Glaxosmithkline, LLC. | $577.17 | 2019-2023 | Trelegy Ellipta |
| Actelion Pharmaceuticals US, INC. | $280.98 | 2019-2023 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $203.06 | 2019-2024 | Winrevair, Dificid, Zerbaxa |
| Astrazeneca Pharmaceuticals Lp | $193.94 | 2019-2024 | Fasenra, Airsupra, Breztri |
| Astellas Pharma US INC | $184.95 | 2022-2024 | |
| Genentech USA, INC. | $163.74 | 2019 | |
| Mylan Specialty L.P. | $152.92 | 2019-2023 | Yupelri |
| Allergan, INC. | $145.69 | 2019-2020 | |
| Stryker Corporation | $127.28 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alcresta Therapeutics, INC. | $123.97 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $121.14 | 2023 | Lifevest |
| Janssen Biotech, INC. | $114.02 | 2024 | Akeega, Erleada |
| Janssen Pharmaceuticals, INC | $71.31 | 2021-2022 | |
| United Therapeutics Corporation | $67.38 | 2021-2023 | Tyvaso |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $50.90 | 2022-2023 | Smartvest |
| Optinose US, INC. | $50.10 | 2019-2020 | |
| Shire North American Group INC | $48.24 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $47.21 | 2022-2023 | Dupixent |
| Kaleo, INC. | $44.33 | 2019-2020 | |
| Grifols USA, LLC | $44.32 | 2019-2021 | |
| Abbvie INC. | $41.49 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $40.67 | 2021-2022 | |
| Philips North America LLC | $38.06 | 2020-2022 | |
| Harmony Biosciences LLC | $33.55 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.12 | 2020 | |
| Baxter Healthcare | $23.17 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $23.11 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.72 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $21.55 | 2020 | |
| Amgen INC. | $20.00 | 2023 | Tezspire |
| La Jolla Pharmaceutical Company | $18.84 | 2021 | |
| Covis Pharma Gmbh | $18.66 | 2019 | |
| Mayne Pharma Commercial LLC | $15.36 | 2020 | |
| Gilead Sciences, INC. | $15.10 | 2021 | |
| Theratechnologies INC. | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.